1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Romanian Pharmaceutical Production Industry 2015

Romanian Pharmaceutical Production Industry 2015

  • December 2014
  • -
  • ManagerAnticriza
  • -
  • 45 pages

This comprehensive research evaluates the Romanian pharmaceutical market on main segments. In order to understand the developments that took place on the Romanian market between 2008-2013 in the first chapter of the research is analyzed the evolution of the global market and its outlook. Also there are financial data of the main players.
The brief analysis of the Romanian macroeconomic framework is the starting point for evaluating and estimating the domestic pharmaceutical market.For each segment are presentend: the evolution between 2008-2013; the features of the market and is made a top 10 of the most important players on the market. Each player is presented in the study and there are provided financial data and indicators for a six year period.

For deepening the research on Romanian pharmaceutical market is made an analysis on NACE codes based on total values at macroeconomic level (total companies that have registered this activity as core business). It is a thorough review where financial indicators such as turnover, net profit, total debt/total assets, total number of companies, number of companies with losses / profits, number of employees, net profit margin are calculated and interpreted for 2008-2013.

In order to support foreign companies planning to enter the Romanian market in the study there were conducted the following types of analyzes: Porter Analysis, PEST Analysis and Value Chain Analysis. Also are listed the most important factors that influence the activity of a market player and recommendations for the management of companies in the sector.

Information and data on pharmaceutical market were obtained from a variety of sources: IMS Institute, IMAP, European Federation of Pharmaceutical Industries and Associations, National Institute of Statistics, National Commission for Prognosis, National Bank of Romania, the National Trade Register Office, Ministry of Finance.

Table Of Contents

Romanian Pharmaceutical Production Industry 2015
EXECUTIVE SUMMARY
I. GLOBAL PHARMACEUTICAL INDUSTRY
1.1. Dynamic and structure of the pharmaceutical industry
1.2. Pharmaceutical industry in global context
1.3. Structure of the industry at the European Union level
II. ROMANIAN PHARMACEUTICAL INDUSTRY
2.1. Landmarks of the domestic macroeconomic context
2.2. Analysis of the Romanian pharmaceutical industry
2.3. Production dynamic in Romania
2.4. Generic medicine
III. MARKET ANALYSIS ON NACE CODES
IV. ROMANIAN COMPETITIVE ENVIRONMENT ANALYSIS
4.1. Competitive environment - top 10 companies
4.2. Competitive environment - main competitors presentation
V. MARKET ANALYSIS ON NACE CODES
V. VALUE CHAIN ANALYSIS
VI. PORTER ANALYSIS
VII. PEST ANALYSIS
VIII. FACTORS OF INFLUENCE
IX. RECOMMENDATIONS

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.